EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liraglutide induces enhanced suppression of food intake in mice lacking the growth hormone secretagogue receptor

Daniela A Cassano, Julieta Aguggia, Lucía Giovanini, Florencia Heredia, Pablo N De Francesco, María F Andreoli, Helgi B Schöth, Abdella M Habib, Gimena Fernandez, Mario Perello

Molecular and Cellular Endocrinology · 2025

DOI: 10.1016/j.mce.2025.112627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Daniela A Cassano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Researc…. Hauptthemen laut MEDLINE: Liraglutide, Receptors, Ghrelin, Eating. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Qatar National Research Fund, Fondo para la Investigación Científica y Tecnológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The glucagon-like peptide-1 receptor (GLP-1R) and the growth hormone secretagogue receptor (GHSR) exert opposing effects on food intake. GLP-1R activation produces potent appetite-suppressing effects, whereas GHSR activation strongly stimulates food intake. Here, we tested the hypothesis that blocking GHSR could affect the anorectic and weight-reducing effects of liraglutide, a GLP-1R agonist widely used to treat diabetes and obesity. We first found that liraglutide induced a stronger reduction in food intake in ad libitum-fed GHSR-deficient mice compared to wild-type (WT) controls, regardless of sex. Liraglutide treatment also resulted in greater gastric content mass in ad libitum-fed GHSR-deficient mice than in WT mice. Interestingly, GLP-1R immunolabeling was elevated in the paraventricular nucleus of the hypothalamus (PVH) in GHSR-deficient mice, whereas the number of proopiomelanocortin (POMC) neurons and liraglutide-induced c-Fos activation-either in the entire arcuate nucleus or specifically within POMC neurons-remained unchanged compared to WT controls. Liraglutide-induced c-Fos expression in the lateral septum and PVH was reduced in GHSR-deficient mice. Conversely, pharmacological GHSR blockade using either JMV2959 or the endogenous antagonist/inverse agonist liver-expressed antimicrobial peptide 2 did not enhance liraglutide-induced food intake reduction. In conclusion, our findings reveal that genetic GHSR deficiency amplifies liraglutide's anorectic effects and provide new insight into the neurobiological mechanisms underlying this interaction. These results suggest that dual modulation of the GHSR and GLP-1R systems may represent a promising strategy for obesity treatment, though careful selection of GHSR-targeting agents and therapeutic protocols will be essential to optimize clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideReceptors, GhrelinEatingAnimalsMaleMice, KnockoutMiceGlucagon-Like Peptide-1 ReceptorFemalePro-OpiomelanocortinMice, Inbred C57BLProto-Oncogene Proteins c-fosParaventricular Hypothalamic Nucleus

Stichwörter der Autor:innen

GLP-1RGhrelinJMV2959LEAP2

Substanzen

LiraglutideReceptors, GhrelinGlucagon-Like Peptide-1 ReceptorPro-OpiomelanocortinProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Laboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University…
  • Instituto de Desarrollo e Investigaciones Pediátricas (IDIP), Children's Hospital HIAEP "Sor María Ludovica" La Plata - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC-PBA), La Plata, Buenos…
  • Department of Surgical Sciences, Functional Pharmacology and Neuroscience, University of Uppsala, Uppsala, Sweden.
  • Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.

Förderung

  • Novo Nordisk Fonden
  • Qatar National Research Fund
  • Fondo para la Investigación Científica y Tecnológica
  • Agencia Nacional de Promoción Científica y Tecnológica

Zitieren

APA

Cassano, D. A., Aguggia, J., Giovanini, L., Heredia, F., De Francesco, P. N., Andreoli, M. F., Schöth, H. B., Habib, A. M., Fernandez, G., & Perello, M. (2025). Liraglutide induces enhanced suppression of food intake in mice lacking the growth hormone secretagogue receptor. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112627

Vancouver

Cassano DA, Aguggia J, Giovanini L, Heredia F, De Francesco PN, Andreoli MF, et al. Liraglutide induces enhanced suppression of food intake in mice lacking the growth hormone secretagogue receptor. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2025.112627

BibTeX
@article{Cassano2025,
  author = {Cassano, Daniela A and Aguggia, Julieta and Giovanini, Lucía and Heredia, Florencia and De Francesco, Pablo N and Andreoli, María F and Schöth, Helgi B and Habib, Abdella M and Fernandez, Gimena and Perello, Mario},
  title = {Liraglutide induces enhanced suppression of food intake in mice lacking the growth hormone secretagogue receptor},
  journal = {Molecular and Cellular Endocrinology},
  year = {2025},
  doi = {10.1016/j.mce.2025.112627}
}
Kostenlos starten →